{
    "clinical_study": {
        "@rank": "43688", 
        "acronym": "MICA", 
        "arm_group": {
            "arm_group_label": "cancer patients", 
            "description": "Patients with stage III or IV esophageal carcinoma, gastric carcinoma, intestinal carcinoma, pancreatic carcinoma, ovarian cancer, breast carcinoma, prostate cancer, urothelial cell carcinoma or lung carcinoma (small cell or non-small cell) who have started chemotherapy no more than 3 months ago"
        }, 
        "biospec_descr": {
            "textblock": "citrated plasma"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "Cancer patients are at increased risk of deep venous thrombosis and pulmonary embolism,\n      collectively termed venous thromboembolism (VTE). Risk assessment scores for VTE in cancer\n      patients have been previously developed by the groups of Khorana and Vienna CATS. However,\n      routine thromboprophylaxis for ambulatory cancer patients based on these scores is currently\n      not recommended. In the investigators prospective, observational cohort study, the\n      investigators aim to identify cancer patients at high risk for VTE based on clinical\n      characteristics, coagulation biomarkers and the coagulant activity of tissue factor bearing\n      microparticles."
        }, 
        "brief_title": "Cohort Study to Identify Cancer Patients at High Risk of Venous Thromboembolism", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Cancer", 
            "Deep Venous Thrombosis", 
            "Pulmonary Embolism"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Embolism", 
                "Pulmonary Embolism", 
                "Thrombosis", 
                "Venous Thrombosis", 
                "Venous Thromboembolism"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Stage III or IV esophageal carcinoma, gastric carcinoma, intestinal carcinoma,\n             pancreatic carcinoma, ovarian cancer, breast carcinoma, prostate cancer, urothelial\n             cell carcinoma or lung carcinoma (small cell or non-small cell) who have started\n             chemotherapy no more than 3 months ago\n\n          -  Chemotherapy started no more than 3 months ago or within 7 days after enrollment\n\n          -  Aged 18 years or older\n\n          -  Written informed consent\n\n        Exclusion Criteria:\n\n          -  Use of anticoagulants (heparin, vitamin K antagonists or direct oral anticoagulants)\n\n          -  Adjuvant chemotherapy  (i.e. after surgery with curative intent)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with stage III or IV esophageal carcinoma, gastric carcinoma, intestinal\n        carcinoma, pancreatic carcinoma, ovarian cancer, breast carcinoma, prostate cancer,\n        urothelial cell carcinoma or lung carcinoma (small cell or non-small cell) who have\n        started chemotherapy no more than 3 months ago"
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 21, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02095925", 
            "org_study_id": "MICA"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 22, 2014", 
        "location": [
            {
                "contact": {
                    "email": "isabelle.mahe@lmr.aphp.fr", 
                    "last_name": "Isabelle Mah\u00e9, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Colombes", 
                        "country": "France", 
                        "state": "Ile-de-France", 
                        "zip": "92700"
                    }, 
                    "name": "Hopital Louis Mourier"
                }, 
                "investigator": {
                    "last_name": "Isabelle Mah\u00e9, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mdinisio@unich.it", 
                    "last_name": "Marcello di Nisio, MD PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Chieti", 
                        "country": "Italy", 
                        "zip": "66013"
                    }, 
                    "name": "Hospital D'Annunziata"
                }, 
                "investigator": {
                    "last_name": "Marcello di Nisio, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "gcesarman@gmail.com", 
                    "last_name": "Gabriela Cesarman, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Mexico City", 
                        "country": "Mexico"
                    }, 
                    "name": "Instituto Nacional de Cancerolog\u00eda"
                }, 
                "investigator": {
                    "last_name": "Gabriela Cesarman, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "h.r.buller@amc.nl", 
                    "last_name": "Harry B\u00fcller, MD PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "state": "Noord-Holland", 
                        "zip": "1105 AZ"
                    }, 
                    "name": "Academic Medical Center"
                }, 
                "investigator": [
                    {
                        "last_name": "Harrr B\u00fcller, MD PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Nick van Es, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Suzanne Bleker, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "P.Nanayakkara@vumc.nl", 
                    "last_name": "Prabath Nanayakkara, MD PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "state": "Noord-Holland", 
                        "zip": "1081 HZ"
                    }, 
                    "name": "VU medical center"
                }, 
                "investigator": {
                    "last_name": "Prabath Nanayakkara, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Hans-Martin.Otten@slz.nl", 
                    "last_name": "Hans-Martin Otten, MD PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "state": "Noord-Holland", 
                        "zip": "1066 EC"
                    }, 
                    "name": "Slotervaart hospital"
                }, 
                "investigator": {
                    "last_name": "Hans-Martin Otten, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "p.w.kamphuisen@umcg.nl", 
                    "last_name": "PW Kamphuisen, MD PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Groningen", 
                        "country": "Netherlands"
                    }, 
                    "name": "University Medical Center Groningen"
                }, 
                "investigator": {
                    "last_name": "PW Kamphuisen, MD PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "France", 
                "Italy", 
                "Mexico", 
                "Netherlands"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "Microparticle's Procoagulant Activity to Identify Patients With Cancer and a High Risk for Venous Thrombosis", 
        "overall_contact": {
            "email": "n.vanes@amc.nl", 
            "last_name": "Nick van Es, MD", 
            "phone": "+31205666023"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "The Netherlands: Medical Ethics Review Committee (METC)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Objectively confirmed asymptomatic or symptomatic deep venous thrombosis or pulmonary embolism", 
            "measure": "venous thromboembolism", 
            "safety_issue": "No", 
            "time_frame": "6 months after enrollment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02095925"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)", 
            "investigator_full_name": "Harry Buller", 
            "investigator_title": "Harry R B\u00fcller, MD PhD", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "measure": "all-cause mortality", 
            "safety_issue": "No", 
            "time_frame": "6 months after enrollment"
        }, 
        "source": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "VU University Medical Center", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University Medical Centre Groningen", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Slotervaart Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "H\u00f4pital Louis Mourier", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Universit\u00e0 degli Studi 'G. d'Annunzio' Chieti e Pescara", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Instituto Nacional de Cancerologia de Mexico", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Harry Buller", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2008", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}